Neo Kid Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2015.
2015 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Neo Kid Pharmaceuticals Private Limited

Neo Kid Pharmaceuticals Private Limited, a struck off private limited company, was established on 02 February 2015 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100TG2015PTC097477. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Sudharani Kasha (Managing Director), Shivarama Chary Kasha (Director). It is based at Flat No 403,4Th Floor,Hig Block8,Chitrapuri Colony Manikonda Jagir Village & Gp, Rajendrana, Gar Mandal, Hyderabad, Telangana, 500089.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2015PTC097477

  • Registration Number

    097477

  • Incorporation Date

    02 February 2015

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 23 Days
Company report

Neo Kid Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neo Kid Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neo Kid Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudharani Kasha Managing Director 02 Feb 2015 Current
Shivarama Chary Kasha Director 02 Feb 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neo Kid Pharmaceuticals.

Enhance accessibility to Neo Kid Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Neo Kid Pharmaceuticals revenue growth over time
Neo Kid Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neo Kid Pharmaceuticals?

Unlock access to Neo Kid Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neo Kid Pharmaceuticals?

Unlock and access historical data on people associated with Neo Kid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neo Kid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neo Kid Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neo Kid Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Sudharani Kasha was appointed as a Managing Director was appointed as a Managing Director on 02 Feb 2015 & has been associated with this company since 11 years 23 days . was completed.

  • Director Appointment

    Shivarama Chary Kasha was appointed as a Director was appointed as a Director on 02 Feb 2015 & has been associated with this company since 11 years 23 days . was recorded as a recent event.

  • Company Incorporation

    Neo Kid Pharmaceuticals Private Limited was registered on 02 Feb 2015 with Roc Hyderabad & aged 11 years 23 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neo Kid Pharmaceuticals Private Limited?

The CIN of Neo Kid Pharmaceuticals Private Limited is U24100TG2015PTC097477.

Where is Neo Kid Pharmaceuticals Private Limited headquartered?

Neo Kid Pharmaceuticals Private Limited is headquartered at Flat No 403,4Th Floor,Hig Block8,Chitrapuri Colony Manikonda Jagir Village & Gp, Rajendrana, Gar Mandal, Hyderabad, Telangana, 500089.

When was Neo Kid Pharmaceuticals Private Limited incorporated?

Neo Kid Pharmaceuticals Private Limited was incorporated on 02 February 2015.

Who are the current directors of Neo Kid Pharmaceuticals Private Limited?

The current directors of Neo Kid Pharmaceuticals Private Limited are

What is the primary industry of Neo Kid Pharmaceuticals Private Limited?

The primary industry of Neo Kid Pharmaceuticals Private Limited is Chemicals.

Is Neo Kid Pharmaceuticals Private Limited a listed company?

Neo Kid Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Neo Kid Pharmaceuticals Private Limited?

The authorized capital of Neo Kid Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Neo Kid Pharmaceuticals Private Limited?

The compliance status of Neo Kid Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available